Hereditary hemorrhagic telangiectasia is regarded as a high hemorrhagic risk condition, and the management of anticoagulation and heart surgery in these patients can be challenging. The authors describe a combined percutaneous treatment of mitral regurgitation and left atrial appendage occlusion in a patient affected by hereditary hemorrhagic telangiectasia and atrial fibrillation, supporting the safety and feasibility of the procedure and the optimal short-Term outcome.
MitraClip™ implantation plus left atrial appendage occlusion in a hereditary hemorrhagic telangiectasia patient
D'Alessandro, P.;Nestola, P. L.;Pepe, M.;Bortone, A. S.
2022-01-01
Abstract
Hereditary hemorrhagic telangiectasia is regarded as a high hemorrhagic risk condition, and the management of anticoagulation and heart surgery in these patients can be challenging. The authors describe a combined percutaneous treatment of mitral regurgitation and left atrial appendage occlusion in a patient affected by hereditary hemorrhagic telangiectasia and atrial fibrillation, supporting the safety and feasibility of the procedure and the optimal short-Term outcome.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
82 MitraClip™ implantation plus left atrial appendage occlusion in a hereditary hemorrhagic telangiectasia patient.pdf
non disponibili
Descrizione: Article
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright dell'editore
Dimensione
3.13 MB
Formato
Adobe PDF
|
3.13 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
